p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes. [electronic resource]
Producer: 20170529Description: 1397-1412 p. digitalISSN:- 1744-7631
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.